Christine Mn Smith

Title: Christine Mn Smith: Innovator in Pharmaceutical Formulations

Introduction

Christine Mn Smith is a notable inventor based in San Diego, CA. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of buffered liquid formulations. Her work focuses on improving treatments for conditions such as hyperinsulinemic hypoglycemia.

Latest Patents

Christine holds 1 patent for her invention titled "Buffered formulations of exendin (9-39)." This patent describes liquid pharmaceutical formulations that include exendin (9-39) or a pharmaceutically acceptable salt, combined with a tonicity modifier in a physiologically acceptable buffer. The formulations are designed to have a pH in the range of about 5 to about 6. In some embodiments, the buffered liquid formulation comprises exendin (9-39) in an acetate buffer or a citrate buffer. The patent also outlines methods for treating or preventing hyperinsulinemic hypoglycemia by administering the buffered liquid formulation to subjects.

Career Highlights

Throughout her career, Christine has worked with prestigious institutions, including Leland Stanford Junior University and Amylyx Pharmaceuticals Inc. Her experience in these organizations has allowed her to contribute to significant advancements in pharmaceutical research and development.

Collaborations

Christine has collaborated with talented individuals in her field, including Xiaofeng Xiong and Colleen M Craig. These partnerships have further enhanced her research and innovation efforts.

Conclusion

Christine Mn Smith is a pioneering inventor whose work in pharmaceutical formulations has the potential to improve treatment options for patients. Her contributions to the field are noteworthy and reflect her dedication to advancing medical science.